Document is current
Any future updates will be listed below
-
Authors
Koutsakos, Marios https://orcid.org/0000-0001-9994-9723
Illing, Patricia T.
Nguyen, Thi H. O.
Mifsud, Nicole A. https://orcid.org/0000-0001-8647-2102
Crawford, Jeremy Chase https://orcid.org/0000-0003-4096-6048
Rizzetto, Simone https://orcid.org/0000-0003-3881-8759
Eltahla, Auda A. https://orcid.org/0000-0002-2995-8832
Clemens, E. Bridie
Sant, Sneha
Chua, Brendon Y.
Wong, Chinn Yi
Allen, E. Kaitlynn
Teng, Don
Dash, Pradyot https://orcid.org/0000-0001-5467-0657
Boyd, David F.
Grzelak, Ludivine
Zeng, Weiguang
Hurt, Aeron C.
Barr, Ian
Rockman, Steve
Jackson, David C.
Kotsimbos, Tom C.
Cheng, Allen C.
Richards, Michael
Westall, Glen P.
Loudovaris, Thomas
Mannering, Stuart I.
Elliott, Michael
Tangye, Stuart G. https://orcid.org/0000-0002-5360-5180
Wakim, Linda M.
Rossjohn, Jamie https://orcid.org/0000-0002-2020-7522
Vijaykrishna, Dhanasekaran
Luciani, Fabio
Thomas, Paul G. https://orcid.org/0000-0001-7955-0256
Gras, Stephanie
Purcell, Anthony W. https://orcid.org/0000-0003-0532-8331
Kedzierska, Katherine https://orcid.org/0000-0001-6141-335X
- License Information
-
More Information
Article History
Received: 13 August 2018
Accepted: 10 January 2019
First Online: 18 February 2019
Competing interests
: S. Rockman is an employee of Seqirus but has no conflict of interest in the material presented. M.K., K.K. and E.B.C. are named as co-inventors in a patent application filed by the University of Melbourne (AU2017903652) covering the use of certain peptides described in the publication as part of vaccine formulation.
